We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck to Buy Rare Disease Company Accleron Pharma for $11.5 Billion
Merck to Buy Rare Disease Company Accleron Pharma for $11.5 Billion
In the second announcement this week of a large drugmaker acquiring a rare diseases-focused company, Merck has agreed to buy Accleron Pharma for $11.5 billion to strengthen its cardiovascular pipeline.